Clinical Trial Update: A Study of ERAS-601 in People With Chordoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers ERAS-601 in people with chordoma and notes that the Phase 1/Phase 2 study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• ERAS-601

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Chordoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING